539 related articles for article (PubMed ID: 17663453)
21. Volatile anesthetic effects on glutamate versus GABA release from isolated rat cortical nerve terminals: 4-aminopyridine-evoked release.
Westphalen RI; Hemmings HC
J Pharmacol Exp Ther; 2006 Jan; 316(1):216-23. PubMed ID: 16174800
[TBL] [Abstract][Full Text] [Related]
22. Facilitation of glutamate release from rat cerebrocortical glutamatergic nerve terminals (synaptosomes) by phosphatidylserine and phosphatidylcholine.
Yang TT; Wang SJ
Synapse; 2009 Mar; 63(3):215-23. PubMed ID: 19072841
[TBL] [Abstract][Full Text] [Related]
23. σ-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings.
Lu CW; Lin TY; Wang CC; Wang SJ
J Pharmacol Exp Ther; 2012 May; 341(2):532-42. PubMed ID: 22357973
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase Cα in rat cerebral cortex nerve terminals.
Kuo JR; Wang CC; Huang SK; Wang SJ
Neurochem Int; 2012 Jan; 60(2):105-14. PubMed ID: 22142530
[TBL] [Abstract][Full Text] [Related]
25. Quercetin inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex.
Lu CW; Lin TY; Wang SJ
Neurotoxicology; 2013 Dec; 39():1-9. PubMed ID: 23933436
[TBL] [Abstract][Full Text] [Related]
26. The modulation of Ca2+ and K+ channels but not changes in cAMP signaling contribute to the inhibition of glutamate release by cannabinoid receptors in cerebrocortical nerve terminals.
del Carmen Godino M; Torres M; Sánchez-Prieto J
Neuropharmacology; 2005 Mar; 48(4):547-57. PubMed ID: 15755482
[TBL] [Abstract][Full Text] [Related]
27. Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca(2+) entry and mitogen-activated protein kinase signaling pathway.
Lin TY; Lu CW; Wang SJ
J Agric Food Chem; 2010 Jul; 58(14):8271-8. PubMed ID: 20593829
[TBL] [Abstract][Full Text] [Related]
28. Partial compensation for N-type Ca(2+) channel loss by P/Q-type Ca(2+) channels underlines the differential release properties supported by these channels at cerebrocortical nerve terminals.
Ladera C; Martín R; Bartolomé-Martín D; Torres M; Sánchez-Prieto J
Eur J Neurosci; 2009 Mar; 29(6):1131-40. PubMed ID: 19302149
[TBL] [Abstract][Full Text] [Related]
29. Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway.
Chang Y; Wang SJ
Eur J Pharmacol; 2010 May; 634(1-3):53-61. PubMed ID: 20193678
[TBL] [Abstract][Full Text] [Related]
30. Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.
Wang SJ; Wang KY; Wang WC; Sihra TS
J Neurosci Res; 2006 Nov; 84(7):1528-42. PubMed ID: 17016851
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals.
Lin TY; Yang TT; Lu CW; Wang SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):598-606. PubMed ID: 21216268
[TBL] [Abstract][Full Text] [Related]
32. Vitamin B2 inhibits glutamate release from rat cerebrocortical nerve terminals.
Wang SJ; Wu WM; Yang FL; Hsu GS; Huang CY
Neuroreport; 2008 Aug; 19(13):1335-8. PubMed ID: 18695519
[TBL] [Abstract][Full Text] [Related]
33. HTDP-2, a new synthetic compound, inhibits glutamate release through reduction of voltage-dependent Ca²⁺ influx in rat cerebral cortex nerve terminals.
Lin TY; Lu CW; Huang SK; Chou SS; Kuo YC; Chou SH; Tzeng WF; Leu CY; Huang RF; Liew YF; Wang SJ
Pharmacology; 2011; 88(1-2):26-32. PubMed ID: 21720189
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by 'pathologically' elevated extraterminal K+ concentrations.
Raiteri L; Zappettini S; Milanese M; Fedele E; Raiteri M; Bonanno G
J Neurochem; 2007 Nov; 103(3):952-61. PubMed ID: 17662048
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol.
Chang Y; Wang SJ
Neurochem Int; 2009 Feb; 54(2):135-41. PubMed ID: 19059293
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
Chang Y; Huang SK; Wang SJ
J Agric Food Chem; 2012 Dec; 60(48):11909-18. PubMed ID: 23167655
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine.
Chiu KM; Lin TY; Lu CW; Wang SJ
Eur J Pharmacol; 2011 Nov; 670(1):137-47. PubMed ID: 21914443
[TBL] [Abstract][Full Text] [Related]
38. Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals.
Wang SJ; Chen HH
Eur J Pharmacol; 2005 May; 514(2-3):141-9. PubMed ID: 15910800
[TBL] [Abstract][Full Text] [Related]
39. Modulation of presynaptic glucocorticoid receptors on glutamate release from rat hippocampal nerve terminals.
Wang CC; Wang SJ
Synapse; 2009 Sep; 63(9):745-51. PubMed ID: 19484722
[TBL] [Abstract][Full Text] [Related]
40. mGluR7 inhibits glutamate release through a PKC-independent decrease in the activity of P/Q-type Ca2+ channels and by diminishing cAMP in hippocampal nerve terminals.
Martín R; Torres M; Sánchez-Prieto J
Eur J Neurosci; 2007 Jul; 26(2):312-22. PubMed ID: 17650109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
